AMDL, MyGene to broaden Asian focus for human papilloma virus test
This article was originally published in Clinica
Executive Summary
Diagnostics firm AMDL has signed an exclusive sublicence with Korean company MyGene International to make the latter's in vitro genotype test for human papilloma virus (HPV) more widely available in the Asian market. The deal will see Tustin, California-based AMDL manufacture, promote, market, distribute and sell the MyGene HPV chip kit in China, Taiwan, Singapore, Malaysia, Thailand, Cambodia and Vietnam.